| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 5 | -322K | 100% | $40.22 | -$13M |
| Net | -5 | -322K | -100% | -$13M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Walter S. Woltosz | Director, 10%+ Owner | $125M | -$11.9M | -8.72% | Sep 3, 2024 |
| John Anthony DiBella | Business Unit President | $3.49M | -$489K | -12.3% | Dec 22, 2023 |
| Jill Fiedler-Kelly | Business Unit President | $669K | Sep 9, 2024 | ||
| David Ralph | Director | $560K | Nov 30, 2021 | ||
| Daniel L. Weiner | Director | $313K | -$344K | -52.4% | Aug 1, 2024 |
| Sharlene Evans | Director | $278K | Aug 1, 2024 | ||
| Lisa LaVange | Director | $245K | -$111K | -31.2% | Sep 3, 2024 |
| John Kenneth Paglia | Director | $173K | -$79K | -31.3% | Aug 1, 2024 |
| William Frederick | Cfo | $91.9K | Oct 24, 2023 | ||
| Steven Chang | President, Immunetrics | Oct 19, 2023 | |||
| Shawn Oconnor | Chief Executive Officer | Oct 19, 2023 | |||
| Brett Howell | Business Unit President | Oct 19, 2023 | |||
| Michael Raymer | Business Unit President | Jun 11, 2024 | |||
| Daniel Szot | Chief Revenue Officer | Mar 28, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|